Already a Bloomberg.com user?
Sign in with the same account.
Roche Holding AG (ROG), which on March 29 raised its hostile bid for Illumina Inc. (ILMN), is in talks with hedge funds that bought Illumina stock following news of the takeover attempt, Finanz & Wirtschaft reported, without saying where it got the information.
Roche, a Basel, Switzerland-based drugmaker, increased its offer to $51 a share after Illumina shareholders told Roche they were interested in accelerating the takeover process, the Swiss newspaper quoted Roche Chief Executive Officer Severin Schwan as saying.
To contact the reporter on this story: Leigh Baldwin in Zurich at firstname.lastname@example.org
To contact the editor responsible for this story: Mariajose Vera at email@example.com